News Releases

Read all the latest news from Bristol Myers Squibb Belgium here.


Sally Ann McNab appointed as General Manager for Bristol Myers Squibb Benelux >
Sally Ann McNab takes on the general management of the Benelux organisation of the global biopharmaceutical company Bristol Myers Squibb.
Sally Ann McNab
New research: Belgian patients and doctors surveyed in the study want attention for mental well-being, educational support and help for caregivers >
Bristol Myers Squibb (BMS), a leading biopharmaceutical company, today published the Belgian results of an intensive listening exercise it conducted as part of its 'Because there is more to do' initiative. Patients, caregivers and health professionals reveal the greatest challenges they face when dealing with a disease, how they feel about pharmaceutical companies and where they think pharma could offer more support.
Belgian 'Because there is more to do' report

New European production facility for CAR T cell therapy in the Netherlands >
As part of its efforts to deliver cell therapy to patients with haematological cancers in Belgium and the rest of Europe, Bristol Myers Squibb is setting up a brand-new CAR T cell therapy production facility in Leiden, Netherlands. 
CAR-T cell therapy production facility in Leiden

Sabine de Beuf
Contact details for media

Didn't find the information you were looking for or do you have further questions? Please contact us directly. We will be happy to help you out!

 

Sabine de Beuf

Head of Corporate Communications, Public Affairs & Patient Advocacy

 

Phone number: +32 2 352 76 11

 

E-mail: pressinfo.belgium@bms.com

For all other questions

If you are not a member of the press and have a non-media related question then find the right contact information here. This will enable us to help you faster!